Literature DB >> 1812992

Antiendothelial cell antibodies in patients with the antiphospholipid syndrome.

R Cervera1, M A Khamashta, J Font, G Ramírez, D D'Cruz, J Montalbán, A López-Soto, R A Asherson, M Ingelmo, G R Hughes.   

Abstract

Antiendothelial cell antibodies (AECA) have been detected in 20 out of 30 patients (67%) with thrombosis associated with antiphospholipid antibodies. Seven patients had systemic lupus erythematosus and 13 had the "primary" antiphospholipid syndrome. Seven patients had both IgG and IgM AECA, 9 had IgG AECA only, and 4 had only IgM AECA. None of 30 control patients with thrombotic events not related to antiphospholipid antibodies had a positive titre of AECA (P less than 0.001). No correlation between AECA, antinuclear antibodies, anti-dsDNA antibodies, anti-neutrophil cytoplasm antibodies, precipitating antibodies to soluble nuclear and cytoplasmic antigens or complement components was found. The possible role of these AECA in the pathogenesis of thrombotic events is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1812992     DOI: 10.3109/08916939108994701

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  12 in total

Review 1.  Antiphospholipid antibodies and the endothelium.

Authors:  B J Hunt; M A Khamashta
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

Review 2.  Antiendothelial cell antibodies (AECA) in systemic lupus erythematosus (SLE).

Authors:  D D'Cruz; M Khamashta; G Hughes
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

3.  The HELLP syndrome, antiphospholipid antibodies, and syndromes.

Authors:  Ronald A Asherson; Claudio Galarza-Maldonado; Jose Sanin-Blair
Journal:  Clin Rheumatol       Date:  2007-10-03       Impact factor: 2.980

Review 4.  What causes the antiphospholipid syndrome?

Authors:  J T Merrill
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

5.  Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding antibody subset.

Authors:  N Nakamura; T Ban; K Yamaji; Y Yoneda; Y Wada
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

Review 6.  Anticardiolipin antibodies and cardiovascular disease.

Authors:  K W Muir
Journal:  J R Soc Med       Date:  1995-08       Impact factor: 5.344

Review 7.  Anti-endothelial cell antibodies and autoimmune diseases.

Authors:  N Del Papa; D Gambini; P L Meroni
Journal:  Clin Rev Allergy       Date:  1994

8.  Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity.

Authors:  R Cervera; M Navarro; A López-Soto; M C Cid; J Font; J Esparza; J C Reverter; J Monteagudo; M Ingelmo; A Urbano-Márquez
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

9.  Characterization and specificity of anti-endothelial cell membrane antibodies and their relationship to thrombosis in primary antiphospholipid syndrome (APS).

Authors:  M B Hill; J L Phipps; R G Malia; M Greaves; P Hughes
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

10.  Complement factor 2 deficiency: a clinical and serological family study.

Authors:  D D'Cruz; J Taylor; T Ahmed; R Asherson; M Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.